Mid-single digit FY22 revenue growth; Q4 results affected by temporary global supply chain impacts and China lockdowns DUBLIN, May 26, 2022 /PRNewswire/ — Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2022, which ended April 29, 2022. Key Highlights FY22 revenue increased 5% reported and organic FY22 GAAP diluted […]
Financial
Anthos Therapeutics Appoints Drew Young as Chief Commercial Officer and Head of Patient Experience
CAMBRIDGE, Mass., May 26, 2022 /PRNewswire/ — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of Drew Young as Chief Commercial Officer and Head of Patient Experience. Mr. Young is joining Anthos at a very exciting time in the company’s young history, bringing over […]
Cardio Diagnostics Announces Headquarters Relocation to Chicago
Pioneer of AI-driven, epigenetics-based clinical tests for cardiovascular disease moves for Chicago’s thriving biotech ecosystem and access to talent and resources CHICAGO, May 25, 2022 /PRNewswire/ — Cardio Diagnostics, Inc. (“Cardio Diagnostics”), a company pioneering AI-driven, epigenetics-based clinical tests for cardiovascular disease (CVD), today announced they have relocated their headquarters to Chicago, Illinois. Cardio Diagnostics will be […]
Dr. Thomas E. MacGillivray Named Chair of Cardiac Surgery for MedStar Heart & Vascular Institute
WASHINGTON, May 25, 2022 /PRNewswire/ — MedStar Heart & Vascular Institute is pleased to announce that Thomas E. MacGillivray, MD, has been named physician executive director of Cardiac Surgery at MedStar Health, and chairman of Cardiac Surgery at MedStar Washington Hospital Center, effective September 1, 2022. Dr. MacGillivray will join MedStar Heart & Vascular […]
NorthStar Medical Radioisotopes Enhances Management Team with Appointment of Monica Andersen as Vice President, Human Resources
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Monica Andersen as Vice President, Human Resources. In this new position, she will hold responsibility for the Company’s Human Resources and […]
Modular Devices Partners with Cardiac Services Mobile
BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–Modular Devices (www.modulardevices.com | www.portable-cleanroom.com), a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners (www.o2investment.com), announced today that it has partnered with Cardiac Services Mobile (www.cardiacservicesinc.com). Ken Harb, CEO of Cardiac, commented, “We are excited about the […]
Salubris Biotherapeutics Announces New Pipeline Advancements and Appointment of Chief Medical Officer
– Lead Clinical Candidate, JK07, Demonstrates Favorable Safety and Further Promising Activity in Cohort 2 of Phase 1b Heart Failure with Reduced Ejection Fraction Study; Enrollment in Cohort 3 Now Ongoing – – Clinical Trial Application Submitted in Europe for Lead Oncology Program JK08, the first CTLA-4/IL-15 Antibody Fusion Protein, […]
Amarin Announces Appointment of New Directors and Board Leadership Changes
Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company’s Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions Reflect Company and Board’s Commitment to Ongoing Refreshment and […]
SANUWAVE Business Update
Sales Funnel Increases 9% and System Trials Increases 5% Month Over Month First Quarter Revenue of $3.2 Million an Increase of 100% Year Over Year SUWANEE, GA, May 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – On May 17, 2022, SANUWAVE Health, Inc. (OTC:PINK: SNWV), a leading provider of next-generation wound care […]
Tenax Therapeutics Announces $8 Million PIPE Offering Priced At-the-Market under Nasdaq Rules
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the issuance and sale […]



